In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 45 for your search:
Drug:  fluorine F 18 fluorothymidine
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080200, 08-C-0200, NCI-08-C-0200, NCI-P07341, 8333, NCT00775268
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: J08101, CA180123, NCT00882583
3.

Phase: Phase II, Phase I
Type: Diagnostic
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: SP-24513/DX-FLT-002, NCT01065805
4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: C/24/2011, 2011-005240-10, X-52-58064-011, NCT01662726
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MIMEB, 2009-012607-26, NCT01047059
6.

Phase: Phase II
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: J08134, NA_00017885, 8340, N01CM27018, NCT00963807
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02012, U10CA021661, CDR0000665163, RTOG 0837, RTOG-0837-ACRIN-6689, NCT01062425
8.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10852, NCT01174238
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA191-011, NCT01225172
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-8029, N01CM27165, ACRIN-6688, NCT00572728
11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 9 to 40
Sponsor: NCI
Protocol IDs: 110136, 11-C-0136, NCT01338987
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 197811, NCI-2011-03037, NCT01533948
13.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120130, 12-C-0130, NCT01610544
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 120199, 12-C-0199, NCT01679743
15.

Phase: Phase I
Type: Diagnostic, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 100, NCT00159978
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000552705, WCCC-CO-06902, CO 06902, 7898, NCT00499135
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579311, MAYO-MC0622, MC0622, NCT00575393
18.

Phase: Phase I
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000647210, P30CA022453, WSU-2006-127, PFIZER-WSU-2006-127, 2006-127, NCT00935090
19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-10080, OSU-10080, 8609, NCT01251874
20.

Phase: Phase I
Type: Diagnostic
Status: Active
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: WSU 2009-031, NCT01308905
21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ABTC-1101, ABTC-1101, NCT01480050
22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CO10907, NCT01540526
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SP-14-0054 / 23061, NCT00414570
24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CDR0000562788, FRE-FNCLCC-FLT-01/0505, EU-20754, FLT 01/0505, NCT00534274
25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Approved-not yet active
Age: 18 to 86
Sponsor: Other
Protocol IDs: TASMC-08-EE-108-CTIL, NCT00688337
1   
New Search